Relationships between insight and medication adherence in outpatients with schizophrenia and bipolar disorder: Prospective study

Psychiatry and Clinical Neurosciences

Volumn 59, Issue 4, 2005, Pages 403-409

  Yen, Cheng Fang ^a,b   Chen, Cheng Sheng ^a,b,c,f   Ko, Chih Hung ^a   Yeh, Ming Li ^d   Yang, Shang Ju ^a   Yen, Ju Yu ^a,c   Huang, Chi Feng ^a   Wu, Chia Chen ^e  

^a KAOHSIUNG MEDICAL UNIVERSITY HOSPITAL   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

^c KAOHSIUNG MUNICIPAL HSIAO KANG HOSPITAL   (Taiwan)

^d ORIENTAL INSTITUTE OF TECHNOLOGY   (Taiwan)

^e FOOYIN UNIVERSITY   (Taiwan)

^f KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Bipolar disorder; Insight; Medication adherence; Schizophrenia

Indexed keywords

ADOLESCENT; ADULT; AGED; ARTICLE; ATTITUDE; BIPOLAR DISORDER; CONTROLLED STUDY; DISEASE DURATION; FEMALE; FOLLOW UP; HAMILTON SCALE; HUMAN; INTERVIEW; MAJOR CLINICAL STUDY; MALE; MENTAL HEALTH; OUTPATIENT; PATIENT COMPLIANCE; POSITIVE AND NEGATIVE SYNDROME SCALE; PROSPECTIVE STUDY; SCHIZOPHRENIA;

ADOLESCENT; ADULT; AGED; ANTIPSYCHOTIC AGENTS; BIPOLAR DISORDER; CROSS-SECTIONAL STUDIES; DEPRESSIVE DISORDER; FEMALE; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; OUTPATIENTS; PATIENT COMPLIANCE; PROSPECTIVE STUDIES; PSYCHIATRIC STATUS RATING SCALES; SCHIZOPHRENIA; SCHIZOPHRENIC PSYCHOLOGY; SOCIOECONOMIC FACTORS;

EID: 23744507506     PISSN: 13231316     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1440-1819.2005.01392.x     Document Type: Article

References (35)

1. Scott J, Pope M. Nonadherence with mood stabilizers: prevalence and predictors. J. Clin. Psychiatry 2002; 63: 384-390.
2. Perkins DO. Predictors of noncompliance in patients with schizophrenia. J. Clin. Psychiatry 2002; 63: 1121-1128.
3. Kulhara P, Basu D, Mattoo SK, Sharan P, Chopra R. Lithium prophylaxis of recurrent bipolar affective disorder: long-term outcome and its psychosocial correlates. J. Affect. Disord. 1999; 54: 87-96.
4. Robinson D, Woerner MG, Alvir JM et al. Predictors of relapse following response from a first episode of schizophrenia or schizoaffective disorder. Arch. Gen. Psychiatry 1999; 56: 241-247.
5. Haywood TW, Kravitz HM, Grossman LS, Cavanaugh JL Jr, Davis JM, Lewis DA. Predicting the 'revolving door' phenomenon among patients with schizophrenic, schizoaffective, and affective disorders. Am. J. Psychiatry 1995; 152: 856-861.
6. Caton CL, Koh SP, Fleiss JL, Barrow S, Goldstein JM. Rehospitalization in chronic schizophrenia. J. Nerv. Ment. Dis. 1985; 173:139-148.
7. Fenton WS, Blyler CR, Heinssen RK. Determinants of medication compliance in schizophrenia: empirical and clinical findings. Schizophr. Bull. 1997; 23: 637-651.
8. Kampman O, Lehtinen K. Compliance in psychoses. Acta Psychiatr. Scand. 1999; 100: 167-175.
9. Guscott R, Taylor L. Lithium prophylaxis in recurrent affective illness. Efficacy, effectiveness and efficiency. Br. J. Psychiatry 1994; 164: 741-746.
10. Yen CF, Yeh ML, Chen CS, Chung HH. Predictive value of insight for suicide, violence, hospitalization, and social adjustment for outpatients with schizophrenia: a prospective study. Compr. Psychiatry 2002; 43: 443-447.
11. McEvoy JP, Freter S, Everett G et al. Insight and the clinical outcome of schizophrenic patients. J. Nerv. Med. Dis. 1989; 177: 48-51.
12. Buchanan A. A two-year prospective study of treatment compliance in patients with schizophrenia. Psychol. Med. 1992; 22: 787-797.
13. Novak-Grubic V, Tavcar R. Predictors of noncompliance in males with first-episode schizophrenia, schizophreniform and schizoaffective disorder. Eur. Psychiatry 2002; 17: 148-154.
14. Bartko G, Herczeg I, Zador G. Clinical symptomatology and drug compliance in schizophrenic patients. Acta Psychiatr. Scand. 1988; 77: 74-76.
15. Ziguras SJ, Klimidis S, Lambert TJ, Jackson AC. Determinants of anti-psychotic medication compliance in a multicultural population. Community Ment. Health J. 2001; 37: 273-283.
16. Budd RJ, Hughes IC, Smith JA. Health beliefs and compliance with antipsychotic medication. Br. J. Clin. Psychol. 1996; 35: 393-397.
17. Garavan J, Bartko G, Gervin M, Lane A, Larkin C, O'Callaghan E. Complaince with neuroleptic medication in outpatients with schizophrenia; relationship to subjective response to neuroleptics; attitudes to medication and insight. Compr. Psychiatry 1998; 39: 215-219.
18. Trauer T, Sacks T. The relationship between insight and medication adherence in severely mentally ill clients treated in the community. Acta Psychiatr. Scand. 2000; 102: 211-216.
19. David AS. Insight and psychosis. Br. J. Psychiatry 1990; 156: 798-808.
20. Amador XF, Strauss DH, Yale SA, Gorman JM. Awareness of illness in schizophrenia. Schizophr. Bull. 1991; 17: 113-132.
21. Wong SS, Lee S, Wat KH. A preliminary communication of an insight scale in the assessment of lithium nonadherence among Chinese patients in Hong Kong. J. Affect. Disord. 1999; 55: 241-244.
22. David A, Buchanan A, Reed A, Almeida O. The assessment of insight in psychosis. Br. J. Psychiatry 1992; 161: 599-602.
23. Smith CM, Barzman D, Pristach CA. Effect of patient and family insight on compliance of schizophrenic patients. J. Clin. Pharmacol. 1997; 37: 147-154.
24. Kemp R, David A. Insight and compliance. In: Blackwell B (ed.). Treatment Compliance and the Therapeutic Alliance. Gordon and Breach, Newark, NJ, 1996; 61-84.
25. American Psychiatric Association. Diagnostic and Statistic Manual of Mental Disorders, 4th edn. APA, Washington, DC, 1994.
26. Blackwell B. Treatment adherence. Br. J. Psychiatry 1976; 129: 513-531.
27. Kay SR. Positive and Negative Syndromes in Schizophrenia: Assessment and Research. Brunner/Mazel, New York, 1991.
28. Cheng JJ, Ho H, Chang CJ, Lan SY, Hwu HG. Positive and Negative Syndrome Scale (PANSS): establishment and reliability study of a Mandarin Chinese language version. Chin. Psychiatry 1996; 10: 251-258.
29. Young RC, Biggs JT, Ziegler VE, Meyer DA. A rating scale for mania: reliability, validity and sensitivity. Br. J. Psychiatry 1978; 133: 429-435.
30. Hamilton M. A rating scale for depression. J. Neurol. Neurosurg. Psychiatry 1960; 23: 56-62.
31. Yen CF, Chen CS, Yeh ML, Ker JH, Yang SJ, Yen JY. Correlates of insight among patients with bipolar disorders in remission. J. Affect. Disord. 2004; 78: 57-60.
32. Yen CF, Yeh ML, Chong MY, Chung HH, Chen CS. A multidimensional assessment of insights in schizophrenic patients. Kaohsiung J. Med. Sci. 2001; 17: 253-260.
33. Sanz M, Constable G, Lopez-Ibor I, Kemp R, David AS. A comparative study of insight scales and their relationship to psychopathological and clinical variables. Psychol Med. 1998; 28: 437-446.
34. Tait L, Birchwood M, Trower P. Predicting engagement with services for psychosis: insight, symptoms and recovery style. Br. J. Psychiatry 2003; 182: 123-128.
35. Yen CF, Chen CS, Yeh ML, Yang SJ, Ker JH, Yen JY. Changes of insight in manic episodes and influencing factors. Compr. Psychiatry 2003; 44: 404-408.